Table I.
Clinical characteristics of 138 patients with Wilms tumor.
| Variable | Patients with Wilms tumor (n=138) |
|---|---|
| Age, years | |
| Median | 3 |
| IQR | 2-5 |
| Overall survival time, months | |
| Median | 77.5 |
| IQR | 44.75–109 |
| Sex | |
| Male | 63 (45.4%) |
| Female | 75 (54.6%) |
| Race | |
| Caucasian | 94 (68.4%) |
| African American | 24 (17.7%) |
| Other | 20 (13.9%) |
| Ethnicity | |
| Local | 86 (62.2%) |
| Hispanic or Latino | 11 (8%) |
| Other | 41 (29.8%) |
| Tumor stage | |
| Stage I | 28 (20%) |
| Stage II | 45 (33%) |
| Stage III | 46 (33%) |
| Stage IV | 10 (7.6%) |
| Stage V | 9 (6.4%) |
| Histology classification | |
| Favorable-histology Wilms tumor | 117 (85.7%) |
| Diffusely anaplastic Wilms tumor | 21 (14.3%) |
| Adverse event | |
| Progression | 3 (2.1%) |
| Relapse | 26 (18.8%) |
| None | 109 (79.1%) |
IQR, interquartile range.